Doris Oesterle

756 total citations
42 papers, 556 citations indexed

About

Doris Oesterle is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Doris Oesterle has authored 42 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 16 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Doris Oesterle's work include Carcinogens and Genotoxicity Assessment (19 papers), Drug Transport and Resistance Mechanisms (7 papers) and Sulfur Compounds in Biology (6 papers). Doris Oesterle is often cited by papers focused on Carcinogens and Genotoxicity Assessment (19 papers), Drug Transport and Resistance Mechanisms (7 papers) and Sulfur Compounds in Biology (6 papers). Doris Oesterle collaborates with scholars based in Germany, Czechia and Slovakia. Doris Oesterle's co-authors include E. Deml, T. Wolff, Jan Topinka, L.R. Schwarz, Friedrich G. Barth, Daniela Diehl, Martin Göttlicher, Uwe Wenzel, Friedrich J. Wiebel and Andreas Hoeflich and has published in prestigious journals such as International Journal of Cancer, Carcinogenesis and Cancer Letters.

In The Last Decade

Doris Oesterle

42 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Oesterle Germany 14 250 194 140 80 73 42 556
John R. Henneman United States 14 143 0.6× 188 1.0× 234 1.7× 123 1.5× 103 1.4× 31 655
Ronny Fransson-Steen Sweden 15 198 0.8× 259 1.3× 121 0.9× 110 1.4× 109 1.5× 23 605
Toyohiko Aoki Japan 14 295 1.2× 394 2.0× 101 0.7× 95 1.2× 108 1.5× 38 757
Yves Barra France 15 105 0.4× 351 1.8× 108 0.8× 133 1.7× 128 1.8× 31 767
Tokuo Sukata Japan 13 185 0.7× 250 1.3× 114 0.8× 89 1.1× 57 0.8× 22 489
Susumu Akasaka Japan 17 202 0.8× 486 2.5× 94 0.7× 184 2.3× 117 1.6× 34 885
Amy Pavone United States 15 135 0.5× 313 1.6× 50 0.4× 141 1.8× 59 0.8× 30 726
Kimimaro Dempo Japan 18 127 0.5× 282 1.5× 131 0.9× 178 2.2× 92 1.3× 44 894
Nancy Thompson Hayner United States 8 163 0.7× 222 1.1× 67 0.5× 135 1.7× 155 2.1× 9 690
Thane S. Thurmond United States 12 316 1.3× 275 1.4× 90 0.6× 102 1.3× 25 0.3× 14 774

Countries citing papers authored by Doris Oesterle

Since Specialization
Citations

This map shows the geographic impact of Doris Oesterle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Oesterle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Oesterle more than expected).

Fields of papers citing papers by Doris Oesterle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Oesterle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Oesterle. The network helps show where Doris Oesterle may publish in the future.

Co-authorship network of co-authors of Doris Oesterle

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Oesterle. A scholar is included among the top collaborators of Doris Oesterle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Oesterle. Doris Oesterle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oesterle, Doris, et al.. (2011). Potential Role of P-gp for Flavone-Induced Diminished Apoptosis and Increased Adenoma Size in the Small Intestine of APCmin/+Mice. Cancer Investigation. 29(6). 396–404. 4 indexed citations
3.
Diehl, Daniela, Doris Oesterle, Ingrid Renner‐Müller, et al.. (2008). IGFBP‐2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis. International Journal of Cancer. 124(9). 2220–2225. 32 indexed citations
4.
Schnäbele, Kerstin, Hannelore Daniel, Doris Oesterle, et al.. (2007). Flavonoids alter P‐gp expression in intestinal epithelial cellsin vitroandin vivo. Molecular Nutrition & Food Research. 51(3). 293–300. 38 indexed citations
5.
Diehl, Daniela, Doris Oesterle, Martin W. Elmlinger, et al.. (2006). IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.. Journal of Carcinogenesis. 5(1). 24–24. 13 indexed citations
6.
Topinka, Jan, Paola Loli, Zuzana Kovačíková, et al.. (2005). Benzo[a]pyrene-enhanced mutagenesis by man-made mineral fibres in the lung of λ-lacI transgenic rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 595(1-2). 167–173. 3 indexed citations
7.
Topinka, Jan, Paola Loli, Mária Dušinská, et al.. (2005). Mutagenesis by man-made mineral fibres in the lung of rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 595(1-2). 174–183. 16 indexed citations
8.
Topinka, Jan, et al.. (2004). No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 550(1-2). 101–108. 9 indexed citations
9.
Topinka, Jan, Paola Loli, Panagiotis Georgiadis, et al.. (2004). Mutagenesis by asbestos in the lung of λ-lacI transgenic rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 553(1-2). 67–78. 30 indexed citations
10.
Loli, Paola, Jan Topinka, Panagiotis Georgiadis, et al.. (2004). Benzo[a]pyrene-enhanced mutagenesis by asbestos in the lung of λ-lacI transgenic rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 553(1-2). 79–90. 12 indexed citations
11.
Wolff, T., Jan Topinka, E. Deml, Doris Oesterle, & L.R. Schwarz. (2001). Dose Dependent Induction of DNA Adducts, Gene Mutations, and Cell Proliferation by the Antiandrogenic Drug Cyproterone Acetate in Rat Liver. Advances in experimental medicine and biology. 500. 687–696. 8 indexed citations
12.
Deml, E., et al.. (1994). C-raf expression in early rat liver tumorigenesis after promotion with polychlorinated biphenyls or phenobarbital. Xenobiotica. 24(6). 569–580. 8 indexed citations
13.
Deml, E., L.R. Schwarz, & Doris Oesterle. (1993). Initiation of enzyme-altered foci by the synthetic steroid cyproterone acetate in rat liver foci bioassay. Carcinogenesis. 14(6). 1229–1231. 24 indexed citations
14.
Oesterle, Doris & E. Deml. (1990). Detection of chemical carcinogens by means of the “rat liver foci bioassay”. Experimental Pathology. 39(3-4). 197–206. 9 indexed citations
15.
Denk, B., et al.. (1990). Dose-dependent emergence of preneoplastic foci in rat livers after exposure to 2-nitropropane. Archives of Toxicology. 64(4). 329–331. 2 indexed citations
16.
Oesterle, Doris, et al.. (1990). Di(2-ethylhexyl)phthalate alters carbohydrate enzyme activites and foci incidence in rat liver. Carcinogenesis. 11(12). 2111–2115. 6 indexed citations
17.
Oesterle, Doris, et al.. (1989). Comparison of three rat liver foci bioassays-incidence of preneoplastic foci initiated by diethylnitrosamine. Carcinogenesis. 10(10). 1891–1895. 9 indexed citations
18.
Deml, E., Friedrich J. Wiebel, & Doris Oesterle. (1989). Biological activity of 2,4,8-trichlorodibenzofuran: promotion of rat liver foci and induction of cytochrome P-450-dependent monooxygenases. Toxicology. 59(3). 229–238. 5 indexed citations
19.
Deml, E. & Doris Oesterle. (1987). Dose-response of promotion by polychlorinated biphenyls and chloroform in rat liver foci bioassay. Archives of Toxicology. 60(1-3). 209–211. 18 indexed citations
20.
Deml, E., et al.. (1984). Drugs and environmental chemicals as promoters.. PubMed. 487–94. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026